Qualgen Recalls Testosterone Pellets Due to Sterility Concerns
Qualgen, LLC is recalling specific lots of Testosterone 87.5mg pellets nationwide due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility for a drug product, which aligns with the rubric criteria for Severe severity (FDA Class II with potential for significant injury).
Plain-English summary
Qualgen, LLC is recalling specific lots of Testosterone 87.5mg pellets, available in 1, 6, 12, and 30-count vials. The recall is being conducted due to a lack of assurance of sterility for the affected product.
The affected lots are C243 (Best Use Date: 11/21/2018), D010 (Best Use Date: 1/11/2019), and D025 (Best Use Date: 1/30/2019). The product was distributed nationwide.
Consumers and healthcare providers should check their inventory for these specific lot numbers and discontinue use if found. The recall is classified as FDA Class II.
The recalled product
- Product
- Testosterone 87.5mg pellet, 1 count (NDC 69761-187-01), 6 count (NDC 69761-187-06), 12 count (NDC 69761-187-12), and 30 count (NDC 69761-187-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013
- Manufacturer
- Qualgen, LLC
- Category
- Drug — Testosterone Pellets
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: C243 BUD: 11/21/2018
- D010 BUD: 1/11/2019
- D025 BUD: 1/30/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Qualgen, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Qualgen, LLC
See all →- LowCompounded testosterone pellet vials carry incorrect lot numbers from printing issue
FDA (Drugs) · 2025-07-23
- HighQualgen Recalls Estradiol Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-11-14
- SevereQualgen Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2018-11-14
- HighRecall of Testosterone 12.5mg Pellet due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- HighQualgen Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-11-14
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighQualgen Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-12-02
- LowQualgen Recalls Testosterone Pellets Due to Incorrect Lot and Expiration Dates
FDA (Drugs) · 2018-07-11
- SevereFDA Recalls Testosterone Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-04
- SevereTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Sterile Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23